Compare MP Materials (MP) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

MP MaterialsTrade

Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

MP Materials vs Recursion Pharmaceuticals Inc — how do they compare? MP Materials trades at $46.86 (market cap $8.25B), while Recursion Pharmaceuticals Inc trades at $4 (market cap $2.31B). The key difference: MP Materials is far larger — about 3.6× Recursion Pharmaceuticals Inc's market cap, and Recursion Pharmaceuticals Inc is trading nearer its 52-week high, MP Materials nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MP Materials for 11 Days and Recursion Pharmaceuticals Inc for 22 Days on average.

	MP	RXRX
Market Cap	$8.25B	$2.31B
Volume	5,934,023	40,478,768
Sector	Basic Materials	Health
52-Week High	$98.65	$6.79
52-Week Low	$38.10	$2.84
Typical Hold Time	11 Days	22 Days
Enterprise Value	$7.73B	$1.83B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MP Materials

No Aura AI signal available yet.

Recursion Pharmaceuticals Inc

RXRX trades at $4.27, down 7.78% today, with a bullish technical signal from moving averages but negative profitability. The company reported a net loss of -$644.76M in 2025, with revenue of $74.26M, and has beaten earnings estimates in two of the last three quarters. Recent news highlights strategic AI partnerships and pipeline expansion, though financial performance remains challenged.

The outlook is mixed: analyst consensus is 40% buy, 60% hold, with no sell ratings, indicating cautious optimism for long-term AI-driven growth. Key risks include persistent cash burn, high valuation multiples, and slow revenue growth. Upside depends on successful drug development and partnership milestones, but near-term profitability remains elusive.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

81% Buy19% Sell

Avg holding period · 11 Days

RXRX

8% Buy92% Sell

Avg holding period · 22 Days

Top news

Latest headlines on both assets

Critical metals stocks fall again; builders like USA Rare Earth drop sharply, producers like MP Materials hold better.24/7 Wall Street · 20 hours agoBearish Rare earth stocks drop 3-5% amid sector-wide selloff without company-specific news.24/7 Wall Street · 1 day agoBearish Pentagon invests $400M in MP Materials to break China's rare earth magnet monopoly, GM first to receive non-China magnets.24/7 Wall Street · 4 days agoBullish View details →

RXRX

View details →

About MP Materials

MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.